Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6346 of 6351
-
A clinical study of CS1-Targeted CAR-T cells in Relapsed/Refractory multiple myeloma
OngoingThis investigator-initiated, exploratory clinical trial is designed to evaluate the feasibility, safety, and preliminary antitumor activity of autologous CS1-targeted chimeric antigen receptor T (CAR-T) cells in adults with relapsed or refractory multiple myeloma (MM). Multiple …
Phase 1 • Sponsor: Qi Junyuan
Last updated Sep 09, 2026 16:00 UTC
-
Hospital-to-Home transitional cardiac rehabilitation as a transition from Centre-Based cardiac rehabilitation after cardiac surgery: a Single-Blind randomised controlled trial
CompletedCardiac rehabilitation (CR) improves outcomes after cardiac surgery, but is usually delivered on a fixed centre-based schedule that requires repeated daytime hospital attendance. A hybrid model, in which supervised training begins in hospital and then transitions to monitored hom…
Sponsor: Cheng-Hsin General Hospital
Last updated Sep 09, 2026 16:00 UTC
-
Investigating the effects of Full-Spectrum medicinal cannabis plant extract 0.08% THC (NTI164) on paediatric acute-onset neuropsychiatric syndrome (PANS)
CompletedThis study investigates the effectiveness of a medicinal cannabis extract (NTI164) with 0.08% THC in treating children with pediatric acute-onset neuropsychiatric syndrome (PANS) over a period of 18 to 54 weeks. Participants, aged 18 to 54, will start with a daily dose of 5mg/kg,…
Phase 1/2 • Sponsor: Fenix Innovation Group
Last updated Sep 09, 2026 16:00 UTC
-
A randomized, wait List-Controlled, clinical trial of IBD strong peer for Self-Management of psychological distress by persons living with inflammatory bowel diseases (IBD)
Recruiting nowPsychological distress (PD) as a result of inflammatory bowel disease (IBD) is prevalent and associated with worse disease-related outcomes. IBD-associated psychological distress (IBD-PD) is particularly common at initial diagnosis, during disease flares, before surgery, and duri…
Sponsor: Jennifer Jones
Last updated Sep 09, 2026 16:00 UTC
-
A multi-center, phase II study to evaluate efficacy and safety of perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, docetaxel (FLOT) and trastuzumab in combination with toripalimab in patients with HER2 positive locally advanced gastric or esophagogastric junction adenocarcinoma
OngoingThis study is a prospective, single arm, multi-center phase II clinical trial designed to evaluate the efficacy and safety of perioperative chemotherapy with FLOT regimen and trastuzumab in combination with toripalimab in participants with resectable HER2 positive locally advance…
Phase 2 • Sponsor: Yu jiren
Last updated Sep 09, 2026 16:00 UTC
-
Understanding changes in the gut microbiome in patients with gallstone disease and its impact on patient outcomes
Recruiting nowThe goal of this prospective observational study is to explore the role of the gut microbiome in patients with gallstone disease. The main question\[s\] it aims to answer are: * if there is a relationship between the gut microbiome and the development of complications associate…
Sponsor: East Kent Hospitals University NHS Foundation Trust
Last updated Sep 09, 2026 16:00 UTC
-
Evaluating the impact of including virtual dietary education within an electronic irritable bowel syndrome pathway
CompletedIrritable bowel syndrome is a functional bowel disorder that affects many Canadians. The syndrome involves abdominal pain and change in frequency or form of bowel movements, and these symptoms can lead to a decreased quality of life for patients. Primary care physicians are dissa…
Sponsor: Nova Scotia Health Authority
Last updated Sep 09, 2026 16:00 UTC
-
Timing and facilitation effects of Theta-Burst stimulation in the reading and language systems
Recruiting nowThe purpose of this study is to understand how transcranial magnetic stimulation affects how quickly, easily, and accurately a person read. Transcranial magnetic stimulation is a technique that uses magnetic fields to briefly affect how well certain brain regions function. The in…
Sponsor: Georgia State University
Last updated Sep 09, 2026 16:00 UTC
-
A mechanistic test of treatment strategies to foster practice quitting
Recruiting nowTobacco use disorder is a chronic, relapsing health condition that necessitates a chronic care approach. However, traditional smoking cessation treatment programs allocate nearly all their resources only to those smokers who are willing to set a quit date. This is problematic bec…
Phase 1/2 • Sponsor: Rush University Medical Center
Last updated Sep 09, 2026 16:00 UTC
-
Genetic determinants of Exercise-Induced muscle damage (POLYGENDOMUS) / déterminants génétiques des dommages musculaires induits par l'Exercice (POLYGENDOMUS)
CompletedThe objective of this study is to evaluate the association between the evolution of plasma CPK levels and genetic polymorphisms, both before the muscle-damaging exercise and at three post-exercise time points. The investigators aim to include 300 participants in this research.
Sponsor: Lille University
Last updated Sep 09, 2026 16:00 UTC
-
A pilot study to evaluate the functional outcome of nanofractures for the treatment of cartilage lesions
Recruiting nowArticular cartilage lesions, with their inherent limited healing potential, remain a challenging problem for orthopaedic surgeons. Various techniques, both palliative and reparative, have been used to treat this injury with variable success rates. If not adequately treated, they …
Sponsor: Ente Ospedaliero Cantonale, Bellinzona
Last updated Sep 09, 2026 16:00 UTC
-
Determination of efficacy of sustained motor contraction generated using StimWave peripheral nerve stimulator
CompletedParalysis is one of the most disabling features of Spinal cord injury and stroke. In select cases, where the nerve is intact, stimulation can achieve meaningful muscle contraction e.g. to restore grip and release function. Previously, products to serve this purpose had been devel…
Sponsor: Walton Centre NHS Foundation Trust
Last updated Sep 09, 2026 16:00 UTC
-
A phase IIa, randomized, parallel, Double-Blind, placebo controlled study to evaluate the efficacy and safety of enpatoran in dermatomyositis and polymyositis participants receiving standard of care (NEPTUNIA)
Stopped earlyThe purpose of this study is to evaluate the efficacy and safety of orally administered M5049 in idiopathic inflammatory myopathies, specifically dermatomyositis (DM) and polymyositis (PM) participants for 24 weeks.
Phase 2 • Sponsor: EMD Serono Research & Development Institute, Inc.
Last updated Sep 09, 2026 16:00 UTC
-
Prospective pharmacogenetic cohort study of CYP2D6 metabolizer phenotype, analgesic failure, and adverse effects in postoperative patients receiving tramadol by elastomeric infusion pump
Recruiting nowThis prospective pharmacogenetic cohort will enroll postoperative patients receiving a standardized tramadol-containing elastomeric analgesia pump. CYP2D6 genotype will be measured but will not determine treatment during the 72-hour study window. Participants with non-normal meta…
Sponsor: Research Inc
Last updated Sep 09, 2026 16:00 UTC
-
A multicenter, open-label extension (OLE) study to evaluate the safety, pharmacodynamics, and clinical effects of WVE-004 in patients with C9orf72-associated amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD)
Stopped earlyThis is an OLE study conducted to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and clinical effects of WVE-004 in adult participants with ALS, FTD, or mixed ALS/FTD phenotype with a documented mutation in the C9orf72 gene. To participate in the…
Phase 1/2 • Sponsor: Wave Life Sciences USA, Inc.
Last updated Sep 09, 2026 16:00 UTC
-
Screening instruments for measuring visual symptoms in victims of concussion
CompletedVisual dysfunction after mild traumatic brain injury (mTBI) is common but often remain undiscovered during longer periods of time. No valid, reliable and easy-to-use screening instrument for uncovering visual dysfunction exists. Furthermore, it is unknown whether optometric measu…
Sponsor: Bispebjerg Hospital
Last updated Sep 09, 2026 16:00 UTC
-
The effect of cold application on nausea and vomiting in the early postoperative period - randomized controlled study
CompletedAs a result of the literature review, it has been seen that it has not yet been clarified whether cold application methods are effective on postoperative nausea and vomiting, and academic studies on this subject are needed. The aim of the planned study was to conduct a randomize…
Sponsor: Zonguldak Bulent Ecevit University
Last updated Sep 09, 2026 16:00 UTC
-
Phase III, multicenter, open-label, randomized clinical trial to evaluate efficacy of sodium zirconium cyclosilicate (Lokelma) compared to standard of care to manage hyperkalemia in patients with chronic kidney disease (CKD)
Recruiting nowPhase III, multicenter, randomized, open-label, parallel-group, non-inferiority, phase III clinical trial comparing CSZ (Lokelma) vs. iSRAA discontinuation/reduction and/or ARM (standard treatment).
Phase 3 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
Last updated Sep 09, 2026 16:00 UTC
-
Clinical and biological responses to repeated administration of low-dose Interleukin-2 in patients with type 1 diabetes and a residual insulin secretion
Recruiting nowType 1 diabetes (T1D) is caused by the destruction of insulin-producing cells by effector T cells (Teffs), due to a deficiency of regulatory T cells (Tregs). Ciclosporin effectively blocks the Teffs and controls diabetes, but cannot be considered as a long-term treatment. Low-do…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris
Last updated Sep 09, 2026 16:00 UTC
-
A phase 1 Open-Label, Single-Dose, Parallel-Group study of the pharmacokinetics and safety of VIR-2218 and VIR-3434 monotherapy and combination therapy in adult participants with hepatic impairment
CompletedIn this study, a single dose of VIR-2218 up to 200 mg SC or VIR-3434 at 300 mg SC monotherapy or a combination of VIR-2218 and VIR-3434 will be administered to assess the pharmacokinetic (PK) exposure, safety, and tolerability of VIR-2218 and VIR-3434 in participants with cirrhos…
Phase 1 • Sponsor: Vir Biotechnology, Inc.
Last updated Sep 09, 2026 16:00 UTC